The present review discusses recent work on melatonin-mediated circadian regulation, the
metabolic and molecular signaling mechanisms that are involved in human breast cancer …

A rising incidence of thyroid cancers (TCs) mainly small tumors, observed during recent
years, lead to many controversies regarding treatment strategies. TCs represent a distinct …

Background Prostate-specific membrane antigen (PSMA) is overexpressed on the
endothelial cells of tumor neo-vessels of several solid malignancies, including differentiated …

Abstract Background and Aim The pathological diagnosis of papillary thyroid carcinoma
(PTC) is usually easily achieved. However distinguishing the follicular variant of papillary …

Abstract Background The BRAF V600E mutation is a recognised molecular marker in
papillary thyroid cancer (PTC), reported incidence from 30 to 80%. BRAF V600E aberrantly …

Aim of the study is to evaluate the expression of CK19, galectin-3, HBME-1, CD56, claudin-1
and neutrophil gelatinase-associated lipocalin (NGAL) in papillary thyroid carcinoma (PTC) …

Context: Anaplastic thyroid cancer cells are characterized by a mesenchymal phenotype, as
revealed by spindle-shaped cells and absent or reduced levels of E-cadherin. Epigenetic …

Intra-tumor heterogeneity results from both genetic heterogeneity of cancer (sub) clones and
phenotypic plasticity of cancer cells that could be induced by different local …

Cancer remains a major public health concern, mainly because of the incompletely
understood dynamics of molecular mechanisms for progression and resistance to …

Background: Metastatic dormancy, or the ability of cancer cells to survive but not progress in
metastatic environments, is now recognized to be a common occurrence in cancer …